Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
    1.
    发明申请
    Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof 有权
    包含牛磺酰胺衍生物和羧酸和/或其盐的抗菌锁

    公开(公告)号:US20020111346A1

    公开(公告)日:2002-08-15

    申请号:US09997970

    申请日:2001-11-30

    发明人: Klaus Sodemann

    IPC分类号: A61K031/549

    摘要: The present invention relates to a method of inhibiting or preventing infection and blood coagulation in or near a medical prosthetic device after said device has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, and (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof, whereby there are no systemic anti-clotting and no systemic biocidal effects.

    摘要翻译: 本发明涉及一种在将所述装置插入病人之后抑制或预防医疗假体装置内或附近的感染和血液凝固的方法,包括向该装置施用药学有效量的组合物,其包含:(A)至少 一种牛磺酰胺衍生物和(B)至少一种选自生物可接受的酸及其生物可接受的盐的化合物,由此不存在全身性抗凝血和全身性杀生物作用。

    Peritoneal dialysis solution with taurolidine
    2.
    发明申请
    Peritoneal dialysis solution with taurolidine 有权
    腹膜透析溶液与taurolidine

    公开(公告)号:US20030225066A1

    公开(公告)日:2003-12-04

    申请号:US10160529

    申请日:2002-05-31

    摘要: The present invention contemplates the addition of 0.5% to 4% taurolidine into solutions used peritoneal dialysis. The taurolidine is intended to prevent or reduce the incidence of infection within the abdomen and/or in the vicinity of an implanted dialysis port. The invention also includes methods using solutions of taurolidine in the flushing and locking of catheters and fluid lines used in peritoneal dialysis.

    摘要翻译: 本发明考虑将0.5%至4%的taurolidine加入到腹膜透析溶液中。 该taurolidine旨在防止或减少在腹部和/或植入的透析口附近的感染的发生率。 本发明还包括使用taurolidine的溶液在用于腹膜透析的导管和流体管线的冲洗和锁定中的方法。